Corbus Pharma Files 10-Q for Q1 2025
Ticker: CRBP · Form: 10-Q · Filed: May 6, 2025 · CIK: 1595097
Sentiment: neutral
Topics: 10-Q, financials, pharmaceuticals
TL;DR
CRBP 10-Q filed for Q1 2025. Financials and agreements updated.
AI Summary
Corbus Pharmaceuticals Holdings, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information, including assets and liabilities, and references various agreements and plans such as the CFF Warrant, Loan Agreement with KTwo Health Ventures LLC, and the 2014 Equity Incentive Plan. The company's business address is 500 River Ridge Drive, Norwood, MA.
Why It Matters
This filing provides investors with an update on Corbus Pharmaceuticals' financial health and operational status for the first quarter of 2025, crucial for investment decisions.
Risk Assessment
Risk Level: medium — The filing is a routine 10-Q, but the company operates in the volatile pharmaceutical sector, which inherently carries significant risks.
Key Players & Entities
- Corbus Pharmaceuticals Holdings, Inc. (company) — Filer
- 20250331 (date) — Reporting Period End Date
- 500 River Ridge Drive, Norwood, MA (location) — Business Address
- KTwo Health Ventures LLC (company) — Party to Loan Agreement
- 2014 Equity Incentive Plan (plan) — Equity Plan Mentioned
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20250331, indicating the first quarter of 2025.
What is Corbus Pharmaceuticals' primary business classification?
The Standard Industrial Classification is 'PHARMACEUTICAL PREPARATIONS [2834]'.
What is the company's business address?
The business address is 500 River Ridge Drive, Norwood, MA, 02062.
Are there any specific loan agreements mentioned in the filing details?
Yes, a 'LoanAgreementMember' is mentioned in relation to 'KTwoHealthVenturesLLCMember' with a date of 2023-06-01.
What type of financial instruments are mentioned regarding fair value measurements?
The filing mentions 'MoneyMarketFundsMember', 'USTreasurySecuritiesMember', and 'CommercialPaperMember' in the context of 'FairValueMeasurementsRecurringMember'.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 6, 2025 regarding Corbus Pharmaceuticals Holdings, Inc. (CRBP).